Lobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats.

TitleLobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats.
Publication TypeJournal Article
Year of Publication2003
JournalPharmacology, biochemistry, and behavior
Volume74
Issue2
Pagination279-86
ISSN0091-3057
Abstract

Lobeline inhibits [3H]nicotine binding to rat brain membranes and nicotine-induced [3H]dopamine release from superfused rat striatal slices, indicating that lobeline acts as a nicotinic receptor antagonist. To determine whether lobeline also inhibits the effects of nicotine in vivo, the present study assessed the effect of lobeline pretreatment on nicotine-induced hyperactivity and sensitization. For 12 consecutive days, rats were injected subcutaneously with lobeline (3 mg/kg) or saline, followed 10 min later by nicotine (0.3 mg/kg) or saline injection, and activity was monitored. To determine if lobeline inhibits induction of sensitization to nicotine, 1 or 28 days later, rats were pretreated with saline followed by nicotine or saline. Lobeline attenuated nicotine-induced hyperactivity when both drugs were administered repeatedly. Although an initial injection of lobeline produced hypoactivity, tolerance to this effect developed. Importantly, tolerance did not develop to the lobeline-induced attenuation of nicotine hyperactivity. Lobeline attenuated the induction of sensitization to nicotine 1 day, but not 28 days, after the cessation of lobeline treatment. These results demonstrate that systemic administration of lobeline attenuates the locomotor-activating effects of repeated nicotine injection and the sensitization to nicotine, consistent with lobeline inhibition of nicotinic receptors and/or neurotransmitter transporters.

URLhttps://linkinghub.elsevier.com/retrieve/pii/S0091305702009966
Short TitlePharmacol Biochem Behav
X
Enter your linkblue username.
Enter your linkblue password.
Secure Login

This login is SSL protected

Loading